药智官方微信
药智官方微博
广州瑞博奥生物科技有限公司，是一家集生物高科技产品研究、生产、销售于一体的中外合资企业，注册资金8624万元，总投资5000万美元，由国际公认的蛋白质芯片科学家黄若磐博士创办。公司成立至今获得多项荣誉： 2010年，广东省引进创新科研团队 2013年，科技部863项目 2014年，“珠三角科技创新创业人才投融资对接集训营（广州站）”最具投资价值项目 2014年，国家人力资源和社会保障部举办的2014年“最具成长潜力的留学人员创业企业”同时公司创始人黄若磐博士也获得以下多项荣誉 2009年，广州开发区科技领军人才 2011年，广州市创业领军人才 2012年，中组部“千人计划”创业型人才公司自主购置了16亩的建设用地，于2011年9月奠基，建设2万5千平米的新园区（一期1万3千平米已经投入使用），其中拥有1300多平米的GMP厂房，将是世界上规模最大、种类最多的蛋白芯片临床诊断产品生产线。 公司率先开发了高品质的抗体和蛋白质芯片技术平台，蛋白质芯片能够同时有效地分析生物样品中参与炎症、血管生长、细胞生长、细胞凋亡及信号转导等数百种蛋白的表达水平。公司致力于为后基因时代的疾病诊疗和生物医学研究开发提供具有创新性和可靠性的技术、服务和产品。为改善医疗诊断、个体化治疗、药物开发和生物标记开发以及加强临床研究的团队提供蛋白质技术平台和用于疾病诊断及个体化医疗的产品。公司自主研发的全自动蛋白芯片分析仪已完成样机制作，并将投入使用，为蛋白芯片试剂的临床应用提供了重要保障。 2013年公司3项发明专利（“一种芯片法邻位连接技术”，“一种检测磷酸化表皮生长因子受体的试剂盒及其制备方法”“一种检测炎症因子的蛋白质芯片试剂盒及其制备方法 ”）正式获得国家知识产权局授权。截止2014年2月公司共计提交18项发明专利。同时公司的两个商标“RayBio” 和 “Quantibody” 已于2014年分别获得第1，5，35，38，42，44类别的商标注册证。公司拥有近400页的产品目录，主要涉及蛋白质芯片、抗体芯片、抗体、免疫试剂、诊断试剂等近万种，公司拥有先进的技术优势、遍布全球的销售网络以及世界各国众多科学家客户中很高的产品美誉度。许多发表在Nature、Nature Medicine、 Cell、 PNAS、Lancet等世界顶级期刊上的文章中均使用了瑞博奥的产品，公司的芯片技术和产品质量都得到了广泛的肯定。
[更多详情]
Quantitative, Sandwich ELISAs for Detection of Soluble Factors in a Variety of Species | ||
 | The RayBio® ELISA kits are in vitro enzyme-linked immunosorbent assays for the quantitative measurement of soluble proteins in a variety of species. Our extensive ELISA selection includes cytokines, growth factors, proteases, soluble receptors, apoptosis effectors, and many other soluble proteins. For a comparison & overview of all our ELISA systems, click here. |  |
Features | Contents of Kit |
|
|
Representative Data | Research Applications |
 |
|
RayBio® EIA kits utilize the principle of Competitive Enzyme Immunoassay (EIA), in which the target protein and a biotin-conjugated peptide bind competitively to a capture antibody. This assay requires only a single antibody, generating signal output by interaction of the biotinylated competitor with streptavidin-HRP. Thus, the EIA kits are particularly useful for detecting peptide hormones and other molecules for which no antibody pair exists, or for which antibody pairs cannot be developed. Browse EIA Kits Compare All ELISA Systems | ||
Another important advantage of the EIA format is broad-species reactivity. For each kit, a peptide derived from a high-homology region of the target protein sequence serves as both the standard and the biotin-labeled competitor. RayBio® EIA kits are validated for rat, mouse, and human samples and have expected reactivity with many other species.
| ||
| Features Contents of KitExcellent for follow up/confirmation of E-Series Array dataBroad species reactivityStrip plate format minimizes wasteComplete kit includes all necessary reagentsHighly sensitive and specificReproducible and reliableOptimized for serum, plasma, and cell culture medium96-well strip plate (12x8)Wash Buffer Concentrate (20x)Standard Peptide Capture antibodyPositive controlDiluent BuffersBiotin-labeled peptideHRP-Streptavidin concentrateTMB One-Step Substrate ReagentStop Solution | ||
Quantitative, Sandwich ELISAs for Detection of Soluble Factors in a Variety of Species | ||
| The RayBio® ELISA kits are in vitro enzyme-linked immunosorbent assays for the quantitative measurement of soluble proteins in a variety of species. Our extensive ELISA selection includes cytokines, growth factors, proteases, soluble receptors, apoptosis effectors, and many other soluble proteins. For a comparison & overview of all our ELISA systems, click here. | |
Features | Contents of Kit |
|
|
Representative Data | Research Applications |
|
|
RayBio® EIA kits utilize the principle of Competitive Enzyme Immunoassay (EIA), in which the target protein and a biotin-conjugated peptide bind competitively to a capture antibody. This assay requires only a single antibody, generating signal output by interaction of the biotinylated competitor with streptavidin-HRP. Thus, the EIA kits are particularly useful for detecting peptide hormones and other molecules for which no antibody pair exists, or for which antibody pairs cannot be developed. Browse EIA Kits Compare All ELISA Systems | ||
Another important advantage of the EIA format is broad-species reactivity. For each kit, a peptide derived from a high-homology region of the target protein sequence serves as both the standard and the biotin-labeled competitor. RayBio® EIA kits are validated for rat, mouse, and human samples and have expected reactivity with many other species.
| ||
| Features Contents of KitExcellent for follow up/confirmation of E-Series Array dataBroad species reactivityStrip plate format minimizes wasteComplete kit includes all necessary reagentsHighly sensitive and specificReproducible and reliableOptimized for serum, plasma, and cell culture medium96-well strip plate (12x8)Wash Buffer Concentrate (20x)Standard Peptide Capture antibodyPositive controlDiluent BuffersBiotin-labeled peptideHRP-Streptavidin concentrateTMB One-Step Substrate ReagentStop Solution | ||
